Aeterna Zentaris
AEZS
$1.97
Share price
-0.51%
Change (1 day)
-38.44%
Change (1 year)
Categories
Aeterna Zentaris (AEZS) - Cash on Hand
Cash on Hand as of September 2023 : $38.75 M
According to Aeterna Zentaris's latest financial reports the company has $38.75 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Aeterna Zentaris - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $50.61 M | -22.49% |
| 2021-12-31 | $65.3 M | 169.05% |
| 2020-12-31 | $24.27 M | 209.66% |
| 2019-12-31 | $7.83 M | -45.99% |
| 2018-12-31 | $14.51 M | 86.53% |
| 2017-12-31 | $7.78 M | -64.63% |
| 2016-12-31 | $21.99 M | -46.93% |
| 2015-12-31 | $41.45 M | 18.66% |
| 2014-12-31 | $34.93 M | -19.14% |
| 2013-12-31 | $43.2 M | 9.31% |
| 2012-12-31 | $39.52 M | -15.7% |
| 2011-12-31 | $46.88 M | 38.16% |
| 2010-12-31 | $33.93 M | -10.94% |
| 2009-12-31 | $38.1 M | -23.37% |
| 2008-12-31 | $49.71 M | 20.13% |
| 2007-12-31 | $41.38 M | -32.17% |
| 2006-12-31 | $61.01 M | 75.04% |
| 2005-12-31 | $34.86 M | -27.87% |
| 2004-12-31 | $48.32 M | -2.64% |
| 2003-12-31 | $49.63 M | -4.16% |
| 2002-12-31 | $51.79 M | 52.5% |
| 2001-12-31 | $33.96 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $13.96 B | 35,925.39% | 🇨🇭 Switzerland |
 Sanofi SNY | $9.92 B | 25,517.04% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $12.28 B | 31,585.42% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | $56.13 M | 44.84% | 🇺🇸 USA |
 Halozyme Therapeutics HALO | $0.33 B | 766.96% | 🇺🇸 USA |